Stay informed and receive company updates straight to your inboxSign up today
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. Applying our Manocept™ technology, Navidea seeks to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. The company, founded in 1983, maintains headquarters in Dublin, Ohio.
4995 Bradenton Avenue
Dublin, OH 43017
Chief Financial and Operating Officer
Vice President, Investor Relations
295 Madison Avenue, 18th Floor
New York, NY 10017